Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 13.90B | 7.13B | 1.08B | 789.28M | 785.23M |
Gross Profit | 3.43B | 1.81B | 504.82M | 277.15M | 232.38M |
EBITDA | 2.01B | 1.10B | 127.47M | 69.64M | 39.91M |
Net Income | 265.95M | 106.20M | 74.64M | 81.26M | 29.36M |
Balance Sheet | |||||
Total Assets | 18.95B | 16.20B | 1.02B | 589.86M | 525.86M |
Cash, Cash Equivalents and Short-Term Investments | 2.36B | 3.67B | 612.90M | 263.53M | 147.85M |
Total Debt | 7.43B | 8.54B | 198.13M | 155.24M | 172.78M |
Total Liabilities | 14.55B | 12.73B | 311.33M | 232.41M | 248.66M |
Stockholders Equity | 1.27B | 945.61M | 708.09M | 357.45M | 277.19M |
Cash Flow | |||||
Free Cash Flow | -302.20M | 666.36M | 33.88M | 131.22M | -244.19M |
Operating Cash Flow | 414.47M | 959.50M | 63.99M | 132.04M | -237.87M |
Investing Cash Flow | -333.90M | 1.48B | -32.51M | 2.38M | -4.10M |
Financing Cash Flow | -1.41B | 70.73M | 318.89M | -18.53M | 231.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥14.29B | 10.50 | 0.40% | -54.70% | -73.05% | ||
78 Outperform | ¥15.37B | 23.32 | 1.00% | 7.42% | 10.13% | ||
70 Outperform | ¥11.91B | 12.32 | 4.06% | 5.96% | -1.58% | ||
67 Neutral | ¥14.70B | 90.55 | ― | 25.52% | 282.24% | ||
63 Neutral | ¥13.27B | 30.11 | ― | 69.06% | 464.48% | ||
63 Neutral | £505.30M | 23.90 | -8.45% | 170.40% | 4.53% | -18.72% | |
59 Neutral | ¥11.63B | 42.96 | ― | 62.19% | 40.77% |